1090.8000 -22.10 (-1.99%)
NSE Nov 20, 2026 15:31 PM
Volume: 209.9K
 

1090.80
-1.99%
BOB Capital Markets Ltd.
Sales/EBITDA/PAT for 4QFY26 reported 8.5%/1.9%/33% above our estimates. ETR reported at 23% vs our estimate of 25%
Senores Pharmaceuticals has lost -29.67% in the last 3 Months
More from Senores Pharmaceuticals Ltd.
Recommended